Recurrent injuries eventually exhaust the capacity of skeletal muscle to fully restore or regenerate its cellular architecture. Therefore a comprehensive understanding of the muscle regeneration programme is needed to provide a platform for new therapies for devastating diseases such as Duchenne muscular dystrophy. To begin to decipher the molecular programme that directs muscle regeneration, we undertook an unbiased strategy using microarray analysis of cardiotoxin-injured skeletal muscle at defined time periods in the adult mouse. Using this strategy, we identified Tceal7 [transcription elongation factor A (SII)-like 7], which was dynamically regulated during muscle regeneration. Our studies revealed that Tceal7 was restricted to the skeletal muscle lineage during embryogenesis. Using transgenic technologies and transcriptional assays, we defined an upstream 0.7 kb fragment of the Tceal7 gene that directed the LacZ reporter to the developing skeletal muscle lineage. Analysis of the Tceal7 promoter revealed evolutionarily conserved E-box motifs within the 0.7 kb upstream fragment that were essential for promoter activity, as mutation of the E-box motifs resulted in the loss of reporter expression in the somites of transgenic embryos. Furthermore, we demonstrated that MRFs (myogenic regulatory factors) were Tceal7 upstream transactivators using transcriptional assays, EMSAs (electrophoretic mobility-shift assays), and ChIP (chromatin immunoprecipitation) assays. Overexpression of Tceal7 in C2C12 myoblasts decreased cellular proliferation and enhanced differentiation. Further studies revealed that p27 expression was up-regulated following Tceal7 overexpression. These studies support the hypothesis that MRFs transactivate Tceal7 gene expression and promote muscle differentiation during muscle development and regeneration.
INTRODUCTION
During mammalian development, skeletal muscle is derived from paraxial mesoderm, which forms segmented epithelial spheres known as somites. These somites serve as a source of progenitors that will further develop into the trunk muscle and limb muscle [1] [2] [3] . In response to co-ordinated cues, which include signalling factors and transcription factors, these myogenic progenitors differentiate in a well-orchestrated fashion during embryogenesis and in the adult skeletal muscle following a severe injury or intense exercise. The capacity for adult skeletal muscle to regenerate and restore its cellular architecture is due to a resident progenitor cell population also known as satellite cells [4, 5] . Satellite cells are small mononuclear progenitor cells, anatomically sandwiched between the basement membrane and sarcolemma of individual muscle fibres. Previous studies have established that satellite cells are involved in the normal growth of muscle, as well as muscle regeneration following injury or disease. In unperturbed muscle, the majority of satellite cells are inactive or quiescent. Following injury associated with intense exercise or disease [i.e. DMD (Duchenne muscular dystrophy)], the satellite cells become activated, they proliferate as skeletal myoblasts, and they differentiate into new muscle cells [4] [5] [6] . Studies suggest that the progenitor cells that participate in muscle development during embryogenesis and regeneration in the adult skeletal muscle may have a common ancestor and that these progenitors may share a common molecular regulatory network [7] [8] [9] [10] .
Previous gene disruption studies have identified transcription factors that regulate myogenic gene expression and muscle development, which include MRFs (myogenic regulatory factors), such as Myod, Myf5, Myf6 and myogenin or Myog [1, 4, 11] . MRFs belong to the bHLH (basic helix-loop-helix) family, they form heterodimers with E proteins (E12 and E47) and they bind to the canonical DNA sequence, CANNTG, referred to as an Ebox motif [12, 13] . The conventional single-and double-knockout studies support the notion that Myod and Myf5 function in specification to the myogenic lineage, Myog is important in the terminal differentiation of muscle, and Myf6 may have a role in both the specification and differentiation of muscle [12, 13] .
The Tceal [transcription elongation factor A (SII)-like] family is characterized as having a TFA (transcription elongation factor A) domain, and this family includes nine members in the human genome and seven members in the mouse genome. Tceal1, the prototypical member of this family, participates in the RSV (rous sarcoma virus) long-terminal-repeat repression [14] [15] [16] . Human TCEAL7 was first identified in an ovarian cancer cell line and has been proposed to negatively regulate cellcycle progression [17, 18] . To further investigate the regulation of muscle regeneration and differentiation, we used the CTX (cardiotoxin)-injury mouse model to identify genes that were dynamically expressed during muscle differentiation. In the present paper, we report that the Tceal7 gene was dynamically regulated and expressed during muscle regeneration. Our studies further define upstream regulators of Tceal7 gene expression and Abbreviations used: bHLH, basic helix-loop-helix; Cdk, cyclin-dependent kinase; ChIP, chromatin immunoprecipitation; CTX, cardiotoxin; EMSA, electrophoretic mobility-shift assay; GFP, green fluorescent protein; HA, haemagglutinin; IRES, internal ribosome entry site; MRF, myogenic regulatory factor; MyHC, myosin heavy chain; PFA, paraformaldehyde; pRb, retinoblastoma protein; RT, reverse transcription; qRT-PCR, quantitative RT-PCR; TBP, TATA-box-binding protein; Tceal, transcription elongation factor A (SII)-like. 1 Correspondence may be addressed to either author (email shixz@umn.edu or garry@umn.edu).
the role of Tceal7 during muscle differentiation. Collectively, these studies define an MRF-Tceal7 cascade that is important in the regulation of muscle differentiation.
EXPERIMENTAL

DNA and RNA manipulation
Myod, Myf5, Myf6, Myog and Tceal7 were cloned into the pcDNA-myc vector using PCR. HA (haemagglutinin)-Tceal7 was subcloned into the pSAM vector for lentiviral overexpression. In addition, the Tceal7 promoter fragment was cloned into the pGL3-TATA vector using PCR. pCMV-Sport6-E12 was purchased from Open Biosystems. The Tceal7 promoter mutagenesis of the E-box motifs was performed by PCR and confirmed by sequence analysis. RNA extraction, Northern blot and RT (reverse transcription)-PCR were performed as previously described [19] . qRT-PCR (quantitative RT-PCR) assays were performed with SYBR green as described previously [19] . Northern blot and mouse MTC (multimedia tissue cDNA) panel were purchased from Clontech. The primers used in the present study are listed in Supplementary Table S1 (at http://www.BiochemJ.org/bj/428/bj4280213add.htm).
EMSA (electrophoretic mobility-shift assay) and ChIP (chromatin immunoprecipitation) assays
pcDNA-Myod and pCMV-Sport6-E12 were used for the in vitro protein synthesis with the TNT ® -coupled transcription/translation system (Promega) according to the manufacturer's instructions. 32 P-labelled probe was synthesized using the EMSA kit and purified by a ProbeQuant G-50 column (GE Healthcare). The probe oligonucleotides are listed in Supplementary Table S1 . Myod and E12 were premixed and incubated at 37
• C for 20 min before incubation with the 32 P-labelled oligonucleotide. The EMSA was performed using the EMSA kit (Promega). Samples were run on a 4 % TBE (Tris/borate/EDTA) non-denaturing gel and imaged using a Typhoon phosphorImager (GE Healthcare). For the supershift assays, 2 μg of anti-Myod serum (Santa Cruz Biotechnology) was added to the reaction mixture for 20 min at room temperature (15-20
• C) after addition of the riboprobe [19] . ChIP assays were performed with the Easy-ChIP kit (Upstate Biotechnologies) according to the manufacturer's protocol. Briefly, C2C12 myotubes were washed with PBS and then cross-linked with 1 % formaldehyde. After washing with PBS, the cells were scraped in PBS supplemented with the protease inhibitor mixture (Roche). Cells were collected and then resuspended in SDS lysis buffer. The cell lysate was sonicated with a 10 s pulse and 50 s pause, which was repeated twice using the Sonic Dismembrator Model 500 (Fisher). The sheared DNA fragments were 200-600 bp, as revealed by gel analysis. The chromatin mixture was diluted with ChIP dilution buffer, precleaned and then incubated with the anti-Myod serum (sc760, Santa Cruz Biotechnology) or anti-rabbit IgG serum (sc2027, Santa Cruz Biotechnology), followed by incubation with Protein A-agarose beads. The immunuprecipitation complex was washed sequentially with a low-salt wash buffer [0.1 % SDS, 1 % Triton X-100, 2 mM EDTA, 20 mM Tris/HCl (pH 8.1) and 150 mM NaCl], a high-salt wash buffer [0.1 % SDS, 1 % Triton X-100, 2 mM EDTA, 20 mM Tris/HCl (pH 8.1) and 500 mM NaCl], a lithium chloride wash buffer [0.25 M LiCl, 1 % Igepal CA630, 1 % deoxycholic acid (sodium salt), 1 mM EDTA and 10 mM Tris/HCl (pH 8.1)] and TE buffer. Agarose beads were eluted twice, and the combined eluates were reverse cross-linked and incubated with proteinase K. DNA was recovered using the Qiagen minicolumn and resuspended in water. Routine PCR was performed with primers flanking the E-box motifs.
Cell transfection and transcriptional assays
NIH 3T3 fibroblasts and C2C12 myoblasts were maintained in complete DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FBS (foetal bovine serum) and 5 % CO 2 at 37
• C in an incubator. Cells were passaged into six-well plates, cultured at a density of (1-1.5) × 10 5 cells per well and transfected with the indicated DNA plasmids using FuGENE ® 6 (Roche) for NIH 3T3 cells or Lipofectamine TM (Invitrogen) for C2C12 cells. The total amount of DNA was normalized with the expression vector DNA. Cells were harvested 24 h later and luciferase assays were performed following a standard protocol with the dualluciferase system (Promega). To evaluate the promoter activity in myotubes, C2C12 cells were transfected as described above, and then switched to the differentiation medium (containing 2 % horse serum) for 48 h. Cells were harvested and luciferase assays were performed as described previously [19] . The GFP + cells were sorted by FACS and further cultured. Tceal7 expression was confirmed using Western blot analysis (anti-HA serum, 3F10 serum, Roche; anti-tubulin serum, Sigma). Infected cells (2 × 10 4 ) were seeded in a six-well plate, and cell growth was quantified and analysed morphologically 60 h later. Infected cells (5 × 10 5 ) were seeded in a two-well chamber slide and cultured in the differentiation medium for 4 days. Cellular differentiation was evaluated using anti-MyHC (myosin heavy chain) serum (Hybridma bank) and immunohistochemical techniques.
CTX-induced muscle regeneration
All adult male C57Bl/6 mice (2-6 months of age) used in these studies were maintained, crossed, genotyped, injected and killed in accordance with an approved Institutional Animal Care and Use Committee Protocol at the University of Minnesota. The CTX (Calbiochem)-induced muscle injury/regeneration model in the adult mouse is an established and reliable model to study muscle regeneration as described previously [20] . Briefly, 0.15 ml of CTX (10 mM) was delivered using an intramuscular injection into the tibialis anterior and gastrocnemius (mixed fibre-type muscle groups) muscles and the mice were killed at defined time periods: control (uninjured), 0.25 days, 0.5 days, 2 days, 5 days, 7 days and 14 days (n = 3 at each time period). The respective muscle groups were harvested and either snap-frozen in liquid nitrogen and stored at − 80
• C (for RNA preparation) or fixed in 4 % (w/v) PFA (paraformaldehyde) and paraffin-processed for in situ hybridization analysis.
In situ hybridization analysis
Image clone AA036186 (from A.T.C.C.) was used to synthesize the in situ probe. The 35 S-labelled antisense 428 bp riboprobe was synthesized using an in vitro transcription kit (Ambion) and then purified using MicroSpin G-50 Columns (Amersham). The sense probe was synthesized as the negative control. The embryos or CTX-injured skeletal muscles were fixed with 4 % (w/v) PFA, embedded in paraffin and sectioned (4 μm in thickness). The samples were dewaxed, permeablized, acetylated and then hybridized to the respective riboprobes. Autoradiographic exposure was for 21 days, after which the sections were rinsed, stained with haematoxylin, dehydrated and coverslipped [20] .
To visualize the sections, we used a Zeiss Axio Imager M1 microscope equipped with a Zeiss EC 10 × Plan-Neofluar optics, a standard bright-field condensor and a dark-field condenser. The photographs were obtained with an AxioCam HRc camera and processed with AxioVision 4.6 software.
Generation of transgenic mice
Wild-type and mutant constructs of the Tceal7 promoter (0.7 kb) were subcloned into the LacZ reporter cassette [19] . The constructs were linearized following EcoRI and BamHI restriction enzyme digestion and then injected into C57BL/6J single-cell embryos, which were implanted into pseudopregnant recipients. Embryos were harvested at defined time periods and PCR and LacZ staining were undertaken to identify the transgenic founders.
LacZ staining
Transgenic embryos were harvested at embryonic day 13.5, fixed in 4 % PFA (pH 7.4) for 60 min at 4
• C, rinsed with the rinse buffer (100 mM NaCl, 2 mM MgCl 2 , 0.01% sodium deoxycholate and 0.02 % Nonidet P40) for 10 min at room temperature (repeated twice), and stained with fresh staining solution [rinse buffer plus 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide and 1 mg/ml X-gal (5-bromo-4-chloroindol-3-yl β-D-galactopyranoside)] overnight at 37
• C, followed by postfixation in 4% PFA overnight at 4
• C. The stained embryos were washed with PBS, visualized by Zeiss Stereo Discovery v.20 macro/stereo microscope with AxioCam MRc5 camera and photographed with AxioVision 6 software [21] .
Statistics
Student's t tests were performed to identify significant differences (P < 0.05) in data obtained from control and experimental samples. Results are presented as means + − S.E.M.
RESULTS
Identification of Tceal7
Adult skeletal muscle has a tremendous capacity for regeneration. Restoration of the cellular architecture is essentially complete within 2-4 weeks following CTX-induced injury that destroys up to 90 % of the muscle [4] . We have used the CTX-injury model, as it is highly reproducible, to study muscle regeneration in the adult mouse [22] . Using microarray analysis, we identified Tceal7 (GenBank ® accession number NM_001127169) as a gene that was dynamically regulated during muscle regeneration. We confirmed these results using RT-PCR and in situ hybridization techniques as we established that Tceal7 is expressed at relatively low levels in unperturbed adult skeletal muscle ( Figures 1A  and 1E ). In all cases, the corresponding sense riboprobe had no signal (Supplementary Figure S1 at http://www.BiochemJ.org/ bj/428/bj4280213add.htm). Following CTX-induced injury, Tceal7 is robustly up-regulated within 5 days of CTX injury, which corresponds to the period associated with muscle differentiation ( Figures 1A-1D , and Supplementary Figure S2 at http://www.BiochemJ.org/bj/428/bj4280213add.htm). At 14 days post-injury, Tceal7 expression is markedly reduced, supporting the notion that this gene has a dynamic role during muscle differentiation ( Figures 1A-1E ). These studies are further complemented by Northern blot analysis, which reveals that Tceal7 is highly expressed during the later embryonic stages (embryonic days 15 and 17), and defines that the mRNA transcript size is approximately 1.35 kb (Figure 2A) . Tceal7 is not detected during early embryogenesis (Figure 2A ) or in the unperturbed adult skeletal muscle (results not shown) using Northern blot analysis. Moreover, our preliminary studies using in situ hybridization techniques to define the temporal and spatial expression pattern for Tceal7 during embryogenesis reveals that it is restricted to the somites and established muscle groups (head, trunk and limb) at embryonic days 11.5 and 13.5 (Figures 2B and Supplementary Figure S3 at http://www. BiochemJ.org/bj/428/bj4280213add.htm). At all developmental time periods examined, Tceal7 expression is restricted to the myogenic lineage. To complement these in vivo expression studies, we examined Tceal7 expression during C2C12 differentiation, which is a widely used in vitro myogenesis model. Tceal7 expression was not detectable in the proliferating myoblasts, but it was up-regulated upon differentiation (Figure 2C) . To confirm the culture conditions and differentiation conditions, we examined myoglobin expression, which is absent from myoblasts and serves as a marker of muscle differentiation ( Figure 2C ) [23] . These in vivo (muscle regeneration studies) and in vitro (i.e. myoblast differentiation studies) expression studies support the notion that Tceal7 is dynamically expressed during muscle differentiation. Tceal7 expression in the multiple tissues was further examined to complement the Northern blot analysis of distinct embryonic stage by cDNA panel analysis ( Figure 2D ). These studies revealed that Tceal7 is highly expressed during the later embryonic stages (embryonic days 15 and 17), but weakly expressed early during embryogenesis (embryonic day 11). Tceal7 is expressed in skeletal muscle, and weakly in the heart, but not in other tissues, such as smooth muscle. Collectively, these preliminary data demonstrate that Tceal7 expression is restricted to the muscle lineage during embryogenesis and muscle regeneration, and further supports the notion that this factor may have a functional role in muscle differentiation based on its temporal expression pattern.
MRF factors regulate the Tceal7 gene
To identify the promoter that directs Tceal7 expression to the muscle lineage, we analysed the Tceal7 genomic locus by rVista (http://rvista.dcode.org/ and [24] ). The mouse Tceal7 upstream 702 bp fragment and human TCEAL7 upstream 717 bp fragment are relatively conserved (Supplementary Figure S4 at http://www.BiochemJ.org/bj/428/bj4280213add.htm). Further analysis of this upstream fragment identified five E-box motifs (E1-E5) in the mouse Tceal7 promoter; three of these E-box motifs were evolutionarily conserved.
To further define the regulatory motifs that govern Tceal7 gene expression, we used transcriptional assays. In addition, we used site-directed mutagenesis of individual E-box motifs that are present within the promoter region to examine the functional role of MRFs and the respective E-box motifs in the regulation of the Tceal7 gene. Using this strategy, we observed that the E1 mutant activity is reduced to 23 %, the E4 mutant activity is reduced to 60 %, and the E5 mutant activity is reduced to 84 % of the wild-type promoter (while E2 and E3 mutant activities are comparable with the wild-type Tceal7 promoter) ( Figure 3A ). Mutations performed in tandem reveal that promoter constructs having E1 and E4 mutations results in ablation of the promoter activity (reduction to 9 % of the control), whereas mutations of all of the E-boxes together results in a reduction of the promoter activity to 6 % of control ( Figure 3A) . These data suggest that each E-box differentially contributes to the promoter activity. Among all of the E-box motifs, the proximal E1 motif appears to have the greatest contribution to the promoter activity. The non-conserved E-box mutations (E2 and E3 mutations) have little impact on Tceal7 activity as measured by luciferease reporter expression. The other two conserved E-box motif mutations (E4 and E5 mutations) cause less activity loss compared with the E1 mutation ( Figure 3A) . To examine the Tceal7 0.7 kb promoter activity in vivo, we fused the 0.7 kb upstream fragment to the LacZ reporter to examine whether this fragment harbours the regulatory motifs to direct expression to the myogenic lineage ( Figure 3B ). We undertook a founder transgenic analysis and observed that this upstream fragment harbours the motifs that direct reporter expression to the somites and established skeletal muscle groups (A) Tceal7 expression during embryonic development. Using Northern blot analysis, Tceal7 is expressed in the mid-gestational (embryonic days 15 and 17) mouse embryos. Tceal7 mRNA is approx. 1.35 kb. E7, E11, E15 and E17 is mouse embryonic days 7, 11, 15 and 17 respectively. (B) Using in situ hybridization, Tceal7 is robustly expressed in the myogenic lineage of the embryonic day 13.5 (E13.5) mouse embryo (left-hand panel is the dark-field image and the right-hand panel is the bright-field image). Arrowheads identify intercostal musculature (open arrow) and diaphragm (filled arrow). Scale bar, 500 μm. (C) Tceal7 is expressed during differentiation of C2C12 myoblasts. Using RT-PCR assays, Tceal7 is expressed in differentiated C2C12 myotubes, but not myoblasts (GM, growth medium; DM, differentiation medium). Myoglobin (Mb) expression is a marker of muscle differentiation in the middle panel; Gapdh (glyceraldehyde-3-phosphate dehydrogenase) expression demonstrates equal loading of input. (D) Tceal7 expression in adult tissues and embryos. 1, heart (whole); 2, brain (whole); 3, spleen; 4, lung; 5, liver; 6, skeletal muscle; 7, kidney; 8, testis; 9, 7 day embryo; 10, 11 day embryo; 11, 15 day embryo; 12, 17 day embryo; 13, placenta; 14, eye (whole); 15, lymph node (whole); 16, smooth muscle; 17, prostate; 18, thymus; 19, stomach; and 20, uterus. Gapdh (glyceraldehyde-3-phosphate dehydrogenase) expression demonstrates equal loading of input.
in the embryonic day 13.5 embryo ( Figure 3C , left-hand panel) similar to the spatial expression pattern for endogenous Tceal7 using in situ hybridization assays. To complement the histochemical assays for LacZ reporter expression, we used immunohistochemical techniques to examine β-galactosidase expression in transgenic embryos (Supplementary Figure S5A at http://www.BiochemJ.org/bj/428/bj4280213add.htm). Using both of these techniques, we observe that the 0.7 kb upstream fragment directs LacZ expression to the somites ( Figure 3C , lefthand panel, and Supplementary Figure S3) . Similarly, we fused the 0.7 kb promoter fragment with all of the E-box mutations to the LacZ reporter gene to evaluate the in vivo function of Ebox motifs during embryogenesis. The LacZ reporter expression, using this mutant construct, reveals essentially an absence of reporter expression using histochemical or immunohistochemical techniques ( Figure 3C , right-hand panel, and Supplementary Figure S5B ). These studies support the conclusion that the 0.7 kb upstream region of the Tceal7 harbours the motifs that directs its expression to the myogenic lineage and that the E-box motifs are essential for Tceal7 expression.
Tceal7 is a MRF target gene
MRFs are master regulators of the myogenic fate as they are capable of converting fibroblasts into the myogenic lineage. MRFs function as master regulators by binding to E-box motifs in the promoters of muscle-specific genes [13]. As noted above, there are five E-box motifs in the 0.7 kb Tceal7 promoter, which direct reporter expression to the muscle lineage. Therefore we tested the hypothesis that MRFs are upstream regulators of Tceal7. As shown in Figure 4 (A), Myod transactivates the 0.7 kb upstream fragment of the Tceal7 gene up to 13-fold in a dose-dependent fashion in NIH 3T3 cells and the transactivation is dramatically reduced when all of the E-box motifs are mutated. Also, we tested three other MRF family members for the transactivation of Tceal7. All of the members activate the Tceal7 promoter, with Myod being the strongest activator and Myog being the weakest transactivator ( Figure 4B ). The direct interaction between the E-box motif and Myod was analysed by EMSA. Myod and E12 heterodimerize to bind to the E4 box directly; the interaction is diminished by the wild-type competitor, but not by the E-box motif mutant competitor, and the interaction is further confirmed by supershift assay ( Figure 4C) . Furthermore, the in vivo interaction between the promoter and Myod was confirmed using the ChIP assay ( Figure 4D ).
Tceal7 inhibits cellular proliferation and promotes cellular differentiation
These studies supported the hypothesis that Tceal7 is a direct MRF downstream target gene. To investigate further its functional role in cell differentiation, we used the lentivirus overexpression system, which included the IRES-GFP cassette to isolate the stable cell lines using FACS analysis ( Figure 5A ). Tceal7 overexpression was confirmed by Western blot analysis ( Figure 5B ). Tceal7 expression is not detectable in the C2C12 myoblasts using RT-PCR ( Figure 1E ), which indicated its negative role in cell proliferation. The Tceal7-overexpression cell is growth-delayed and the total cell number is approx. 70 % of the control cells after 60 h in culture ( Figures 5C  and 5D ). These results support the notion that Tceal7 plays an anti-proliferation role. To further explore its functional role in cellular differentiation, experimental and control cells were seeded in growth medium and then exposed to differentation medium for 4 additional days. The cell differentiation is enhanced in Tceal7-overexpression cells ( Figure 5E ). To further understand the molecular programme during cellular proliferation and differentiation, the expression of the cell-cycle regulatory genes were analysed using qRT-PCR. Interestingly, only p27 is up-regulated, whereas the expression of other Cdk (cyclindependent kinase) inhibitors (p18, p19, p21, and p57) and the pRb (retinoblastoma protein) family is unchanged. These results support the hypothesis that Tceal7 induces p27 expression, which in turn represses proliferation and promotes cell differentiation.
DISCUSSION
The muscular dystrophies are marked by cycles of injury (or degeneration) and regeneration [25] . Although skeletal muscle has a remarkable capacity for repair, ultimately the regenerative process fails and results in the demise of patients. The definition of regulatory cascades is important to enhance our understanding of the molecular mechanisms of muscle regeneration and to serve as a prelude for future therapies for these patients with severe myopathies. Specifically, the definition of factors that regulate muscle differentiation will lead to strategies that will enhance repair and regeneration in injured aged and diseased muscles. In the present study, we undertook an unbiased screen to identify factors that regulate muscle regeneration. Our studies provide two important discoveries that have an impact on the field of muscle regeneration. Our first discovery is the identification of the Tceal7 gene which is tissue-restricted to the myogenic lineage and participates in muscle differentiation.
Human TCEAL7 was initially identified using differential hybridization assays in ovarian cancer cell lines [17] . In addition, TCEAL7 has been shown to be down-regulated in breast cancer, glioblastoma multiforme and prostate cancers [18] . Despite these initial preliminary studies of human TCEAL7, little is known with regard to its functional role. In the present study, we identified Tceal7 as a protein that is differentially expressed during muscle development and regeneration. We further established that Tceal7 was tissue-restricted to the myogenic lineage during development and was dynamically expressed during muscle differentiation using in vitro and in vivo models. The Tceal7 expression patterns observed during muscle regeneration in mice and cell differentiation in an in vitro cell culture model strongly suggests that Tceal7 plays an important function role in muscle differentiation. This expression pattern for Tceal7 is in contrast with the expression pattern for genes such as MCK (muscle creatine kinase), myoglobin or MyHC where expression is increased coincident with differentiation and is maintained in the adult skeletal muscle. Tceal7 expression is transient with increased expression occuring during the onset of differentiation, and this expression pattern suggests that Tceal7 does not function to maintain muscle differentiation. Our studies may also support a unique role for Tceal7 in the transition of myoblasts to the differentiated state, but not in the maintainance of differentiation.
Our second discovery is the definition of Tceal7 as a direct downstream target of MRFs. In the present study, we identified a 0.7 kb upstream fragment of the Tceal7 gene that directs expression to the myogenic lineage. We further established that members of the bHLH Myod family bind to evolutionarily conserved E-box motifs and direct expression of Tceal7 to the myogenic lineage. Our studies further support that the transcriptional regulation of Tceal7 is similar to that of the desmin gene [26] . Within the desmin promoter, there are two E-box motifs, one that is located proximal to the TATA box and another E-box located in the distal region of the desmin gene. Studies using site-directed mutagenesis of the proximal E-box reduces most of the desmin promoter activity, whereas mutation of the distal E-box or Mef2 motifs attenuate the promoter activity to a similar level. In addition, it has been reported that the proximal E-box (in the desmin promoter) provides a docking site for Myod, which stabilizes the TBP (TATA-box-binding protein) to the TATA box site. Moreover, these studies support the notion that TBP promotes Myod activity [27] . The organization of the promoter and the results of the present study suggest that Tceal7 is a MRF direct target gene. Each MRF member favours their own E-box motif extension sequence outside of the conserved CANNTG sequence. In the present study, Myod is the strongest activator of Tceal7, whereas Myog gives the lowest level of activation. Previous studies support the conclusion that Myod plays a critical role in myogenic lineage specification, whereas Myog is required for the muscle terminal differentiation. Whereas the present study suggests that the MRFs are sufficient for Tceal7 expression, we also recognize the possibility that epigenetic mechansisms, including the methylation status, may also regulate gene expression in the myoblast/myotube differentiation assay. These epigenetic regulatory mechanisms may explain, in part, why the MRFs and desmin are co-expressed temporally in the developing skeletal muscle lineage and why Tceal7 expression lags behind the expression of MRFs in myoblasts. Previous studies have demonstrated that TCEAL7 is inactivated by methylation in human ovarian cancer [17] . Moreover, recent studies suggest that methylation status may dynamically regulate gene expression during development and cellular differentiation [28] . For example, studies support a dramatic genome-wide demethylation in differentiating myoblasts in response to the removal of serum [28] . Future studies will need to examine the co-ordinated role of methylation and transcriptional regulation (MRFs) of Tceal7 gene expression during myogenic differentiation.
In the present study, we further explored the function of Tceal7 during cellular proliferation and differentiation. We hypothesize that Tceal7 enhances p27 expression upon differentiation. p27 was first identified as a Cdk2 inhibitory activity detected in contact-inhibited or TGFβ (transforming growth factor β)-treated cells [29, 30] . Loss of the p27 gene results in increased body size, hyperplasia of several organs, female infertility and impaired cell differentiation [31] [32] [33] . In muscle development, p27 is highly expressed in embryo development, but down-regulated in the adult. Furthermore p27 is one of the early-response genes upon serum withdrawal in vitro cell culture [34] . Tceal7 might function as an upstream regulator for p27 expression. We did not detect any changes in cyclin D expression, which may be a result of the cell line used in these studies. Further studies using gene-disruption technology will be important to decipher the role of Tceal7 in the developing and regenerating skeletal muscle.
Collectively, our studies define a new MRF-Tceal7 cascade that is specific to the myogenic lineage and is transiently expressed during transformation to the differentiation stage. The results of these studies further define a myogenic programme which has a discrete role that is shared during development and regeneration of the myogenic lineage. Future studies will use genetic in vivo strategies to further unveil the role of Tceal7 and its family members.
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SUPPLEMENTARY ONLINE
EXPERIMENTAL
Immunohistochemistry
Mouse embryos were fixed with 4 % (w/v) PFA, embedded in paraffin and sectioned as described previously [1] . Following deparaffinization and rehydration, sections were subjected to antigen retrieval by controlled microwave treatment for 20 min in 10 mM citrate buffer, pH 6.0. After rinsing and blocking, sections were incubated with a rabbit polyclonal antibody against β-galactosidase (Abcam) followed by incubation with Cy3 (indocarbocyanine)-conjugated anti-rabbit IgG antibody (Jackson Immunoresearch). Slides with sections were rinsed and coverslipped using Vectashield (Vector laboratories). Images were obtained using a Zeiss Axio Imager M1 microscope with an AxioCam HRc camera and photographed with AxioVision 4.6 software. The conserved nucleotides are indicated with an asterisk. The TATA box is underlined and labelled. The E-boxes in the mouse genome and the conserved E-boxes in human genome are underlined and marked E1-E5. (A) Using immunohistochemical techniques and antisera that recognizes β-galactosidase protein, the wild-type 0.7 kb upstream fragment directs expression to the myogenic lineage in the embryonic day 13.5 embryo at low magnification (left-hand side, scale bar, 500 μm) and high magnification (right-hand side, scale bar, 50 μm). (B) Mutation of the E-box motifs that are embedded within the 0.7 kb upstream fragment of the Tceal7 gene ablates reporter expression using immunohistochemical techniques. Scale bar, 500 μm. Wt, wild-type; Mut, mutant.
